tiprankstipranks
Trending News
More News >
Definium Therapeutics (DFTX)
NASDAQ:DFTX
US Market

Definium Therapeutics (DFTX) Income Statement

Compare
2,206 Followers

Definium Therapeutics Income Statement

Last quarter (Q4 2025), Definium Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Definium Therapeutics's net income was $-50.44M. See Definium Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -527.00K$ -3.16M$ 0.00$ 0.00
Operating Expenses
$ 166.31M$ 103.39M$ 90.70M$ 66.33M$ 93.85M
Depreciation and Amortization
$ 0.00$ 527.00K$ 3.16M$ 3.18M$ 2.62M
EBITDA
$ -178.31M$ -105.87M$ -92.57M$ -63.15M$ -91.24M
Operating Income
$ -166.31M$ -103.92M$ -93.87M$ -66.33M$ -93.85M
Other Income/Expenses
$ -17.48M$ -4.76M$ -1.87M$ 9.54M$ -339.00K
Pretax Income
$ -183.79M$ -108.68M$ -95.73M$ -56.80M$ -94.19M
Net Income
$ -183.79M$ -108.68M$ -95.73M$ -56.80M$ -93.04M
Per Share Metrics
Basic EPS
$ -2.06$ -1.54$ -2.44$ -1.53$ -3.40
Diluted EPS
$ -2.06$ -0.15$ -2.44$ -1.53$ -3.40
Weighted Average Shares Outstanding
89.33M 70.46M 39.16M 30.86M 27.38M
Weighted Average Shares Outstanding (Diluted)
89.33M 704.61M 39.16M 30.86M 27.38M
Currency in USD

Definium Therapeutics Earnings and Revenue History